|
GB9005958D0
|
|
Treatment of polycystic ovarian disease
|
|
US5268278A
|
|
Genetic expression of somatostatin as hybrid polypeptide
|
|
EP0173145A2
|
|
Reduction of the toxic effects caused by anthraquinone drugs
|
|
IT8548029D0
|
|
TREATMENT OF PARASITIC DISEASES
|
|
EP0160190A2
|
|
Genetic expression of somatostatin as hybrid polypeptide
|
|
EP0131552A2
|
|
Purified seminal antigenic fraction, process for its preparation and use of said fraction for the dosage of the spermagglutinating antibodies
|
|
US4493830A
|
|
Method for the treatment of idiopathic headache attacks, in particular migraine and cluster headache
|
|
AU2393884A
|
|
Mixtures of fsh and lh from pig hypophyses in a definite ratio
|
|
AU1988383A
|
|
Composition for treating myocardial infarction
|
|
ES518389A0
|
|
PROCEDURE FOR OBTAINING A PHARMACEUTICAL COMPOSITION CONTAINING ORGOTEIN.
|
|
IL67359D0
|
|
Compositions for intimate feminine hygiene comprising an antiseptic agent and a nutrient for lactobacillus acidophilus
|
|
IT8148551D0
|
|
Antiinflammatory compsns. contg. orgotein
|
|
IL58584D0
|
|
Extemporaneous preparation of liposomes incorporating active substances
|
|
US3992514A
|
|
Radioimmunoassay method for human chorionic gonadotropin in the presence of luteinizing hormone
|
|
US3966700A
|
|
Process for preparing synthetic L-pyroglutamyl-L-histidyl-L-prolinamide
|
|
US3966915A
|
|
Treatment of heart diseases
|
|
US3895115A
|
|
Method of inhibiting platelet aggregation
|
|
CH587865A5
|
|
Reagent for radio-immunoassay of testosterone - by reacting testerone-oxime with tyrosine ester
|
|
GB1400938A
|
|
Process for preparing a testosterone conjugate ester
|
|
IL43554D0
|
|
Process for preparing testosterone-3-(3-carboxymethyl)-oxime-tyrosine methyl ester
|
